title: New liposomal liver-specific contrast agent for CT: first human phase I clinical trial assessing efficacy and safety.
authors.affiliation: Department of Diagnostic Radiology, Malmö University Hospital, Lund University, Sweden.
authors.forename: P
authors.initials: P
authors.lastname: Leander
authors.forename: P
authors.initials: P
authors.lastname: Höglund
authors.forename: Y
authors.initials: Y
authors.lastname: Kloster
authors.forename: A
authors.initials: A
authors.lastname: Børseth
mesh_terms: D003287:Contrast Media / Q000009:adverse effects; D005260:Female; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage*; D008099:Liver / Q000000981:diagnostic imaging*; D008297:Male; D014057:Tomography, X-Ray Computed; D014283:Triiodobenzoic Acids / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D003287:Contrast Media; D008081:Liposomes; D014283:Triiodobenzoic Acids; C044834:iodixanol